LSD-Derived anxiety treatment shows promise in Mid-Stage trial
NCT ID NCT05407064
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study tested four different doses of MM120 (a form of LSD) against a placebo in 198 adults with generalized anxiety disorder. The goal was to see which dose best reduces anxiety symptoms over 4 weeks, using a standard anxiety rating scale. Participants were randomly assigned to receive a single dose of MM120 or placebo, and their anxiety levels were tracked for 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY, GENERALIZED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Adams Clinical
Watertown, Massachusetts, 02472, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
CNS Healthcare - Orlando
Orlando, Florida, 32801, United States
-
Cedar Clinical Research
Draper, Utah, 84020, United States
-
Cedar Clinical Research - Murray
Murray, Utah, 84107, United States
-
GMI - Princeton Medical Institute
Princeton, New Jersey, 08540, United States
-
Great Lakes Clinical Trials
Chicago, Illinois, 60640, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
Irvine Center for Clinical Research
Irvine, California, 92614, United States
-
Kadima Neuropsychiatry Institute
La Jolla, California, 92037, United States
-
Lutheran Hospital - Cleveland Clinic
Cleveland, Ohio, 44113, United States
-
Mountain View Clinical Research
Denver, Colorado, 80209, United States
-
Pacific Neuroscience Institute
Santa Monica, California, 90404, United States
-
Preferred Research Partners
Little Rock, Arkansas, 72211, United States
-
SISU
Springfield, Massachusetts, 01103, United States
-
Segal Trials
Lauderhill, Florida, 33319, United States
-
Sunstone Therapies
Rockville, Maryland, 20850, United States
-
University of Texas Health Houston
Houston, Texas, 77054, United States
-
Uptown Research
Chicago, Illinois, 60640, United States
-
Wholeness Center
Fort Collins, Colorado, 80525, United States
-
Woodstock Research Center
Woodstock, Vermont, 05091, United States
-
iResearch Atlanta
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.